AI-generated summary
The authors report a case series of seven people with Parkinson's disease who received remote photobiomodulation to the abdomen and neck three times weekly for 12 weeks, followed by home treatment. They report improvements in several clinical signs, including mobility, cognition, dynamic balance, spiral test and sense of smell, with improvements varying by individual and some lost during lockdown periods. As a small uncontrolled case series, these findings are limited and do not establish effectiveness.
- Participants
- 7
- Who or what was studied
- Seven participants with Parkinson's disease
- Limits stated in the abstract
- Small uncontrolled case series of seven participants, with improvements varying by individual and some lost during COVID-19 lockdown periods.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.